Table 5.
Postoperative outcome: cardiac and noncardiac related mortality.
| Series | Type of valve | Valve in valve | Mortality 30 d | Mortality 1 yr | Cardiac mortality 30 d | Cardiac mortality 1 yr |
|---|---|---|---|---|---|---|
| Makkar et al. [42] | Sapien | 9 (5%) | 55 (31%) | 8 (4%) | 35 (20%) | |
| Kodali et al. [14] | Sapien | 12 (3%) | 84 (24%) | 11 (3%) | 47 (14%) | |
| Thomas et al. [12, 13] | Sapien | 3 (1%) | 29 (6%) | 88 (19%) | 45 (10%) | |
| Thomas et al. [12, 13] | Sapien | 19 (3%) | 59 (10%) | 156 (27%) | ||
| Himbert et al. [10] (TF) | Sapien | 1 (2%) | 4 (8%) | 6 (12%) | 3 (6%) | 2 (4%) |
| Himbert et al. [10] (TA) | Sapien | 2 (8%) | 4 (16%) | 8 (32%) | 2 (8%) | 0 |
| Grube et al. [9] | CoreValve | 3 (2%) | 17 (13%) | 25 (18%) | ||
| Litzler et al. [15] | Sapien | 8 (13%) | 16 (26%) | |||
| Tamburino et al. [16] | CoreValve | 24 (4%) | 39 (6%) | 99 (15%) | ||
| Avanzas et al. [17] | CoreValve | 1 (1%) | 8 (7%) | 15 (14%) | 6 (6%) | |
| Kempfert et al. [11] | Sapien | 17 (6%) | 26 (9%) | 78 (26%) | ||
| Gotzmann et al. [18] | CoreValve | 12 (8%) | ||||
| Bleiziffer et al. [19] | Sapien and CoreValve | 26 (11%) | 70 (25%) | 4 (1.7%) |